Abstract

Thousands of proteins circulate in the bloodstream; identifying those which associate with weight and intervention-induced weight loss may help explain mechanisms of diseases associated with adiposity. We aimed to identify consistent protein signatures of weight loss across independent studies capturing changes in body mass index (BMI). We analysed proteomic data from studies implementing caloric restriction (Diabetes Remission Clinical trial) and bariatric surgery (By-Band-Sleeve), using SomaLogic and Olink Explore1536 technologies, respectively. Linear mixed models were used to estimate the effect of the interventions on circulating proteins. Twenty-three proteins were altered in a consistent direction after both bariatric surgery and caloric restriction, suggesting that these proteins are modulated by weight change, independent of intervention type. We also integrated Mendelian randomisation (MR) estimates of the effect of BMI on proteins measured by SomaLogic from a UK blood donor cohort as a third line of causal evidence. These MR estimates provided further corroborative evidence for a role of BMI in regulating the levels of six proteins including alcohol dehydrogenase-4, nogo receptor and interleukin-1 receptor antagonist protein. These results indicate the importance of triangulation in interrogating causal relationships; further study into the role of proteins modulated by weight in disease is now warranted.

Details

Title
Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome
Author
Goudswaard, Lucy J. 1 ; Smith, Madeleine L. 2 ; Hughes, David A. 2 ; Taylor, Roy 3 ; Lean, Michael 4 ; Sattar, Naveed 5 ; Welsh, Paul 5 ; McConnachie, Alex 6 ; Blazeby, Jane M. 7 ; Rogers, Chris A. 8 ; Suhre, Karsten 9 ; Zaghlool, Shaza B. 9 ; Hers, Ingeborg 10 ; Timpson, Nicholas J. 2 ; Corbin, Laura J. 2 

 University of Bristol, Population Health Sciences, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603); MRC Integrative Epidemiology Unit, Bristol, UK (GRID:grid.5337.2); University of Bristol, Physiology, Pharmacology & Neuroscience, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603) 
 University of Bristol, Population Health Sciences, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603); MRC Integrative Epidemiology Unit, Bristol, UK (GRID:grid.5337.2) 
 Newcastle Magnetic Resonance Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212) 
 University of Glasgow, Human Nutrition, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary & Life Sciences, Glasgow, UK (GRID:grid.8756.c) (ISNI:0000 0001 2193 314X) 
 University of Glasgow, School of Cardiovascular and Medical Science, Glasgow, UK (GRID:grid.8756.c) (ISNI:0000 0001 2193 314X) 
 University of Glasgow, Robertson Centre for Biostatistics, School of Health and Wellbeing, Glasgow, UK (GRID:grid.8756.c) (ISNI:0000 0001 2193 314X) 
 University of Bristol, Population Health Sciences, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603) 
 Bristol Trials Centre, University of Bristol, Bristol Medical School, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603) 
 Weill Cornell Medicine - Qatar, Department of Biophysics and Physiology, Doha, Qatar (GRID:grid.416973.e) (ISNI:0000 0004 0582 4340) 
10  University of Bristol, Physiology, Pharmacology & Neuroscience, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603) 
Pages
21077
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2895071728
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.